Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells

被引:0
|
作者
Condiotti, R
Nagler, A [1 ]
机构
[1] Hadassah Univ Hosp, Dept Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Israel Natl Cord Blood Bank, IL-91120 Jerusalem, Israel
关键词
interleukin-12; interleukin-2; human umbilical cord blood; natural killer cells; bone marrow; non-major histocompatibility complex-restricted cytotoxicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin (IL)-12, a natural killer (NK) cell stimulatory factor, is a heterodimeric cytokine that is known to be a potent activator of non-major histocompatibility complex-restricted cytotoxicity by peripheral blood-derived NK cells. NK cells (CD3(-)CD16(+)/CD56(+)) represent approximately 15% of human umbilical cord blood mononuclear cells (HUCB MNCs) and are known to be highly sensitive to activation by IL-2. In the present study, we monitored the effect of IL-12 on the cytotoxic activity, proliferation, and phenotypic expression of HUCB-derived resting and IL-2-activated cytotoxic cells and compared these parameters with those of bone marrow (BM)derived cells. Lymphocytes were separated from HUCB by 3% gelatin sedimentation and incubated with IL-12 and/or IL-2 for 18 hours. At effector:target ratios of 40:1 and 20:1, IL-12 (50 U/mL) significantly increased both resting and IL-2-activated NK cell-mediated cytotoxicity in a standard Cr-51-release assay against both NK-sensitive (K562) and NK-resistant (Colo-205) cell lines. In addition, resting and IL-2-activated cytotoxic cells derived from HUCB exhibited superior cytolytic ability compared with BM-derived cells. This increase was observed in resting cells as well as in those that were preincubated with IL-12. Moreover, HUCB-derived cells were found to be more sensitive to IL-12 activation than cytotoxic cells from BM. To evaluate the involvement of accessory cells, NK cells were purified from HUCB using immunomagnetic beads, and these cells were found to have a lower response to treatment with IL-12 than unpurified populations. HUCB MNCs exhibited a nonsignificant increase in proliferation after IL-12 treatment and were better able to respond to IL-12 activation than BM MNCs. Following an 18-hour incubation, IL-12 was able to cause upregulation of CD25 and CD69 activation antigens, whereas no significant change in expression of CD16 and CD56 NK cell surface antigens, CD3 on T cells, or IL-12 receptor was observed. Similarly, IL-12 did not affect NK cell:target cell conjugation as assessed by fluorescence-activated cell sorting. Our results indicate that HUCB-derived NK-mediated cytotoxic capabilities can be increased by IL-12, a finding that may have clinical relevance.
引用
收藏
页码:571 / 579
页数:9
相关论文
共 50 条
  • [41] Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells
    S-J Lin
    L-Y Wang
    Y-J Huang
    M-L Kuo
    Bone Marrow Transplantation, 2001, 28 : 439 - 445
  • [42] Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells
    Lin, SJ
    Wang, LY
    Huang, YJ
    Kuo, ML
    BONE MARROW TRANSPLANTATION, 2001, 28 (05) : 439 - 445
  • [43] Biology of umbilical cord blood progenitors in bone marrow niches
    Dao, Mo A.
    Creer, Michael H.
    Nolta, Jan A.
    Vertaillie, Catherine M.
    BLOOD, 2007, 110 (01) : 74 - 81
  • [44] Effects of Conditioned Medium from Bone Marrow Cells on Human Umbilical Cord Perivascular Cells
    Kajiyama, Sohtaro
    Nagashima, Yuri
    Funatsu, Taichiro
    Suzuki, Takuma
    Fukaya, Meri
    Matsushima, Yuji
    Nagano, Takatoshi
    Davies, John E.
    Gomi, Kazuhiro
    TISSUE ENGINEERING PART A, 2021, 27 (5-6) : 382 - 389
  • [45] STIMULATION OF RATS FETUSES GROWTH BY TRANSPLANTATION OF RATS BONE MARROW CELLS OR HUMAN UMBILICAL CORD BLOOD CELLS DURING GASTRULATION
    Ivolgin, D.
    Mikhailov, V. M.
    Sokolova, A.
    CYTOTHERAPY, 2019, 21 (05) : S66 - S66
  • [46] ANTITUMOR EFFECT OF THE EXTRACT OF HUMAN UMBILICAL-CORD
    MKRTCHYAN, LN
    TERPOGOSYAN, ZR
    NERSESYAN, AK
    PETANOVA, EV
    MARTIROSYAN, SO
    VOPROSY ONKOLOGII, 1990, 36 (08) : 956 - 960
  • [47] Phenotypic changes of T-lymphocyte subsets induced by interleukin-12 and interleukin-15 in umbilical cord vs. adult peripheral blood mononuclear cells
    Lin, SJ
    Chao, HC
    Yan, DC
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2001, 12 (01) : 21 - 26
  • [48] Genetically engineered human umbilical cord-derived mesenchymal stromal cells expressing human interleukin-12 and in vitro growth inhibition against lung adenocarcinoma cells
    Goh, Jiunn-Jye
    Ong, Hooi-Tin
    Lee, Bee-Sun
    Teoh, Hoon-Koon
    MALAYSIAN JOURNAL OF PATHOLOGY, 2023, 45 (02) : 247 - 259
  • [49] Antitumor activity of normal bone marrow cells
    Avdeev, IV
    Seledtsov, VI
    Prokopenko, IV
    Seledtsova, GV
    Kozlov, VA
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1995, 120 (08) : 826 - 828
  • [50] INTERLEUKIN-12 DIRECTLY ENHANCES THE PROLIFERATION, MYELOID DIFFERENTIATION AND VIABILITY OF PRIMITIVE MURINE AND HUMAN BONE-MARROW PROGENITOR CELLS
    JACOBSEN, SEW
    VEIBY, OP
    LIEN, E
    SMELAND, EB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 20 - 20